UPDATE : Wednesday, June 19, 2019
상단여백
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’
In the past, HIV and AIDS were known as deadly diseases that could take awa...
by Kim Yun-mi  |  2019-04-18 15:20
라인
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why?
Novartis’ new treatment for macular degeneration might have to fight agains...
by Kim Yun-mi  |  2019-04-18 14:42
라인
Small drugmakers celebrate export deals worth ₩18.3 billion
The Ministry of Health and Welfare and the Korea Health Industry Developmen...
by Kwak Sung-sun  |  2019-04-17 17:20
라인
Shinpoong’s acute ischemic stroke treatment wins government support
Shinpoong Pharmaceutical said Tuesday that the Ministry of Food and Drug Sa...
by Lee Han-soo  |  2019-04-17 12:42
라인
IVI gets $15.7 million to conduct P3 trials for Vi-DT typhoid conjugate vaccine
The International Vaccine Institute (IVI) said it has received a $15.7 mill...
by Lee Han-soo  |  2019-04-17 10:24
라인
Genexine’s immunotherapeutic drug candidate wins orphan drug status
Genexine and NeoImmuneTech said Tuesday that the U.S. Food and Drug Adminis...
by Lee Han-soo  |  2019-04-16 14:02
라인
GSK unveils further positive data for B-cell maturation antigen
GSK Korea said Monday that it presented additional positive data for DREAMM...
by Lee Han-soo  |  2019-04-15 16:45
라인
Daewoong releases P3 trial results for BTX in international journal
Daewoong Pharmaceutical said Monday that it has published the phase 3 clini...
by Lee Han-soo  |  2019-04-15 14:29
라인
Immunotherapies’ liver cancer-treating effects confirmed in real-world studies
Researchers unveiled the world’s first real-world data to show how immunoth...
by Kim Yun-mi  |  2019-04-15 14:29
라인
Pharmacists’ group demand legalizing abortion pill Mifegyne
In the wake of the Constitutional Court’s ruling that abortion ban is uncon...
by Song Soo-youn  |  2019-04-12 15:20
라인
Doctors skeptical about GSK’s new HIV drug despite FDA nod
The U.S. Food and Drug Administration recently approved GSK’s combination d...
by Kim Yun-mi  |  2019-04-11 13:55
라인
Hana says US Cosmo submits new drug application for Remimazolam
U.S.-based Cosmo Pharmaceutical has submitted a new drug application (NDA) ...
by Lee Han-soo  |  2019-04-10 17:51
라인
WHO grants PQ certification to SK Bioscience’s trivalent flu shot
SK Bioscience said Wednesday that it has received the prequalification (PQ)...
by Lee Han-soo  |  2019-04-10 12:52
라인
'MSD’s monitoring scheme damaged doctors’ trust in drugmaker’
Physicians who run their clinics went furious with MSD Korea after learning...
by Choi Gwang-seok  |  2019-04-10 11:49
라인
CrystalGenomics to expand export accord with PharmArtis
CrystalGenomics said Tuesday that it has expanded its export agreement for ...
by Lee Han-soo  |  2019-04-09 18:14
라인
Bukwang to start P2 trials dyskinesia treatment in Europe
Bukwang Pharmaceutical said Tuesday that it has gathered global researchers...
by Lee Han-soo  |  2019-04-09 17:31
라인
Biogen’s orphan drug Spinraza to get reimbursement
Biogen’s Spinraza (ingredient: nusinersen), a treatment for spinal muscular...
by Lee Han-soo  |  2019-04-09 15:50
라인
Peripheral neuropathy reported in liver cancer drug Stivarga
The Korean health authorities said they would update approval condition for...
by Lee Hye-seon  |  2019-04-09 15:25
라인
Hanmi, Enzychem challenge Amgen in neutropenia treatment
Hanmi Pharmaceutical and Enzychem Lifesciences are gearing up to fight agai...
by Jeong Sae-im  |  2019-04-09 12:15
라인
Kolon confirms cancerous cell lines in Invossa
Kolon Life Science has confirmed cancerous cell lines in Invossa-K, a degen...
by Lee Han-soo  |  2019-04-09 11:16
-12345678910-
‘Keytruda will become most sold orphan drug worldwide by 2024’‘Keytruda will become most sold orphan drug worldwide by 2024’
여백
Most viewed
여백
Opinion
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
여백
Back to Top